PYXS
Pyxis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.76
+4.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 12.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.83x
- Price / sales
- 13.30x
- Price / cash flow
- -2.16x
Enterprise value
- Enterprise value
- $131.6M
- EV / sales
- 11.93x
- EV / EBITDA
- -1.58x
- EV / EBIT
- -1.43x
- Market cap
- $146.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026